Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Pharma MES 2025Pharma MES 2025
Not Confirmed
Not Confirmed
10-11 October, 2025
Not Confirmed
Not Confirmed
11-14 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Pharma MES 2025Pharma MES 2025
Industry Trade Show
Not Confirmed
10-11 October, 2025
Industry Trade Show
Not Confirmed
11-14 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
10 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/health-canada-approves-slenyto---extended-release-melatonin-formulation---as-a-prescription-drug-for-insomnia-in-children-with-autism-spectrum-disorder-and-smith-magenis-syndrome-302552663.html
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-receives-european-marketing-authorization-for-pediatric-prolonged-release-melatonin-slenyto-for-the-treatment-of-insomnia-in-children-with-attention-deficit-hyperactivity-disorder-adhd-302411183.html
31 Jul 2024
// PHARMABIZ
30 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-receives-positive-chmp-opinion-on-slenyto-pediatric-prolonged-release-melatonin-for-the-treatment-of-insomnia-in-children-with-neurogenetic-disorders-ngds-302209423.html
ABOUT THIS PAGE